1 te element modeling, mechanical testing, and
immunohistochemical analyses at multiple time points thr
2 Immunohistochemical analyses confirmed selective ChR2 ex
3 Biochemical and
immunohistochemical analyses confirmed the TSPO small-an
4 nation, immunoprecipitation, microscopy, and
immunohistochemical analyses demonstrated that CDCP1 pro
5 Histological and
immunohistochemical analyses demonstrated the presence o
6 Immunohistochemical analyses for CEACAM1 were performed
7 e PSIONIC-derived prognostic TFs, we perform
immunohistochemical analyses in 31 uterine serous tumors
8 n vivo fluorochrome labeling, histology, and
immunohistochemical analyses indicated that excessive bo
9 We performed
immunohistochemical analyses of 26 PDACs and 5 nonneopla
10 We performed
immunohistochemical analyses of colon tissues from patie
11 Immunohistochemical analyses of CRC tissues further corr
12 Immunohistochemical analyses of hagfish tissues and bloo
13 (PS2APP) from 8 to 13 mo of age, followed by
immunohistochemical analyses of microglia, amyloid, and
14 Immunohistochemical analyses of PHF8, PKCalpha, and PTEN
15 quence, whole-exome and genome sequence, and
immunohistochemical analyses of select samples.
16 Further,
immunohistochemical analyses of the spinal cords of trea
17 Diagnosis is based on histological and
immunohistochemical analyses of tissue from a lymph node
18 e chain reaction analyses of 166 samples and
immunohistochemical analyses of tissue microarrays that
19 Immunohistochemical analyses of TP73 expression was also
20 anwhile, histological immunofluorescence and
immunohistochemical analyses revealed a high level of ap
21 Immunohistochemical analyses revealed consistent high ex
22 Immunohistochemical analyses revealed that lentiviral ve
23 Immunohistochemical analyses revealed that metastases pr
24 Biochemical and
immunohistochemical analyses revealed that radiation red
25 Immunohistochemical analyses revealed that the neurologi
26 Immunohistochemical analyses showed increased nuclear lo
27 Immunohistochemical analyses showed intense peri-islet i
28 We used
immunohistochemical analyses to compare levels of PRL an
29 tissues and performed immunofluorescence and
immunohistochemical analyses to study gastric cell proli
30 toxylin & Eosin, and Masson's Trichrome) and
immunohistochemical analyses using KI67, CD31, TGF-beta,
31 generally focused on mRNA quantification and
immunohistochemical analyses, both of which provide limi
32 binding, an effect confirmed by port-mortem
immunohistochemical analyses, suggesting that upregulati
33 nd alveolar/peripheral cytokine response and
immunohistochemical analyses, we delineated cellular imm
34 mals were sacrificed and brains prepared for
immunohistochemical analyses.
35 umor growth, confirmed with histological and
immunohistochemical analyses.
36 soforms in muscle fibres by western blot and
immunohistochemical analyses.
37 PCR, enzyme-linked immunosorbent assay, and
immunohistochemical analyses.
38 uted tomography and through histological and
immunohistochemical analyses.
39 nes were determined by qRT-PCR, western, and
immunohistochemical analyses.
40 Immunohistochemical analysis also revealed higher chondr
41 retina whole mounts, we combined structural
immunohistochemical analysis and a functional assessment
42 Immunohistochemical analysis and fluorescence in situ hy
43 Immunohistochemical analysis confirmed ABCB1 induction i
44 Immunohistochemical analysis confirmed ABCB1 induction i
45 Immunohistochemical analysis confirmed increased express
46 Second, western blot and
immunohistochemical analysis confirmed that Sal-1 suppre
47 Immunohistochemical analysis confirms increased extracel
48 Hence, its routine
immunohistochemical analysis could be used clinically to
49 Immunohistochemical analysis demonstrated that the inhib
50 Immunohistochemical analysis demonstrated that YC-1 + GI
51 Immunohistochemical analysis documented early abnormalit
52 -operatively, and the specimens submitted to
immunohistochemical analysis for BD-2 and BD-3, as well
53 med, followed by biodistribution studies and
immunohistochemical analysis for gal-3 and NIS expressio
54 Tumors were subjected to
immunohistochemical analysis for immune checkpoints (PD-
55 ge to differ according to race, we performed
immunohistochemical analysis for proteins mechanisticall
56 d over an independent set of 368 ICCs and by
immunohistochemical analysis of 64 ICC tissue samples.
57 of the PET scans, brains were harvested for
immunohistochemical analysis of ABCB1 and AB levels.
58 of the PET scans, brains were harvested for
immunohistochemical analysis of ABCB1 and Abeta levels.
59 Retrospective
immunohistochemical analysis of bone marrow specimens fr
60 Immunohistochemical analysis of brain tissue and dura re
61 Immunohistochemical analysis of brain tissue from two CY
62 epithelial brushings, pathway analysis, and
immunohistochemical analysis of bronchial biopsy specime
63 Immunohistochemical analysis of Claudin-2 and/or Afadin
64 Immunohistochemical analysis of cSCC tissue sections and
65 allow for hematoxylin and eosin staining and
immunohistochemical analysis of formalin-fixed, paraffin
66 Immunohistochemical analysis of HNSCC tumor arrays showe
67 Immunohistochemical analysis of human carotid plaques an
68 Immunohistochemical analysis of Ki67 and cleaved caspase
69 Immunohistochemical analysis of KS expression was perfor
70 Immunohistochemical analysis of liver from the one BASM
71 Disease severity was measured via
immunohistochemical analysis of pancreata measuring loss
72 ted in PDAC, which was also confirmed by our
immunohistochemical analysis of PDAC tissue microarray.
73 We also performed
immunohistochemical analysis of PPARD levels in 2 sets o
74 Molecular and
immunohistochemical analysis of renal function, tissue d
75 ettsial species in tick salivary glands, and
immunohistochemical analysis of the attachment site iden
76 Immunohistochemical analysis of the MAP2K1 downstream ta
77 Immunohistochemical analysis of the mouse brain revealed
78 confirmed with nerve conduction studies and
immunohistochemical analysis of the neuromuscular juncti
79 Immunohistochemical analysis of the retina revealed that
80 Immunohistochemical analysis of the tumorous lungs showe
81 Immunohistochemical analysis of the xenograft tissues re
82 Western blot and
immunohistochemical analysis of tissue from temporal lob
83 rcoma; documented loss of INI1 expression by
immunohistochemical analysis or biallelic SMARCB1 (the g
84 Immunohistochemical analysis revealed a reduction in apo
85 Immunohistochemical analysis revealed cytoplasmatic and
86 Immunohistochemical analysis revealed microglial or macr
87 Immunohistochemical analysis revealed perivascular, neur
88 Immunohistochemical analysis revealed regional differenc
89 Immunohistochemical analysis revealed smaller beta-cell
90 Ex vivo patch clamp electrophysiology and
immunohistochemical analysis revealed that alpha-klotho
91 Immunohistochemical analysis revealed that compared to s
92 Immunohistochemical analysis revealed that the expressio
93 In the present study,
immunohistochemical analysis reveals a spatiotemporal ex
94 Immunohistochemical analysis showed a significantly high
95 Immunohistochemical analysis showed that Hic-5 is primar
96 Immunohistochemical analysis showed that TRAF1 expressio
97 Here we use detailed
immunohistochemical analysis to document the expression
98 Hematoxylin and eosin (H&E) and
immunohistochemical analysis was conducted.
99 Furthermore,
immunohistochemical analysis was performed on surgical b
100 l history or tissue available for review and
immunohistochemical analysis were excluded.
101 By means of
immunohistochemical analysis, all GIST cells expressed C
102 , including classification, histological and
immunohistochemical analysis, and donor- specific antibo
103 ngs were studied with the use of seven-color
immunohistochemical analysis, micro-computed tomographic
104 eers using quantitative noninvasive devices,
immunohistochemical analysis, mRNA sequencing, and quant
105 lasts were measured through radiographic and
immunohistochemical analysis, respectively.
106 Based on detailed
immunohistochemical analysis, we postulated the recipien
107 uled removal of the implant and prepared for
immunohistochemical analysis.
108 examined using mouse periodontium tissues by
immunohistochemical analysis.
109 therapy from 192 patients were available for
immunohistochemical analysis.
110 ival tissues was also assessed using in situ
immunohistochemical analysis.
111 o underwent cardiac surgery and subjected to
immunohistochemical analysis.
112 Immunohistochemical and electron microscopic evaluations
113 d, and demonstrate partial correlations with
immunohistochemical and electron microscopy measures of
114 In
immunohistochemical and enzyme-linked immunosorbent assa
115 nfiltration of TAMs and CTLs as evidenced by
immunohistochemical and flow cytometric analysis.
116 Immunohistochemical and immunoblot staining of midbrain
117 tinal tissues were collected and analyzed by
immunohistochemical and immunofluorescence analyses.
118 inflammation and senescence were assessed by
immunohistochemical and immunofluorescence staining of h
119 igins of proguanylin, complementing previous
immunohistochemical and in-situ hybridisation results.
120 We here evaluated morphometric,
immunohistochemical and messenger RNA (mRNA) expression
121 Significant strides in the
immunohistochemical and molecular signature of AITL have
122 We used
immunohistochemical and quantitative polymerase chain re
123 ased site from each patient and prepared for
immunohistochemical and reverse transcription, quantitat
124 s argynnis, and Rousettus aegyptiacus, using
immunohistochemical and stereological techniques.
125 oses (25-300 mug/g b.w.) were analyzed using
immunohistochemical and ultrastructural procedures.
126 In this study, we performed bioinformatics,
immunohistochemical,
and biochemical analyses to examine
127 We used behavioral, electrophysiological,
immunohistochemical,
and chemogenetic strategies to targ
128 esults of these histological, histochemical,
immunohistochemical,
and dynamic histomorphometric analy
129 whole-mounts were evaluated by quantitative,
immunohistochemical,
and intracellular labeling approach
130 On right kidney histopathological and
immunohistochemical,
and on the left kidney biochemical
131 By combining ultrastructural,
immunohistochemical,
and Western blotting analyses, we f
132 ns in the gastrointestinal tract, we used an
immunohistochemical approach in normal adult rat small i
133 the present work, we combined transgenic and
immunohistochemical approaches to investigate the neuroa
134 ined anterograde and retrograde tracing with
immunohistochemical approaches to investigate the patter
135 navirus 2 (SARS-CoV-2) through molecular and
immunohistochemical assays and by and electron microscop
136 Analysis of
immunohistochemical assays using antibodies targeting th
137 Immunohistochemical assessment of LAT1/LAT2/CD98 amino a
138 we could show that the
immunohistochemical assessment of MYC and the histomorph
139 Tissue microarray was performed to evaluate
immunohistochemical-
based molecular subtype.
140 Electrophysiological,
immunohistochemical,
biochemical, and pharmacological ex
141 Histological,
immunohistochemical,
biochemical, functional, and behavi
142 ession of this newly identified and verified
immunohistochemical biomarker, with a sensitivity of 97%
143 c decision making and thus requires reliable
immunohistochemical biomarkers.
144 emaining graft particles, histochemical, and
immunohistochemical (
bone morphogenetic protein 2/4 [BMP
145 Diffuse
immunohistochemical C4d staining of capillary endothelia
146 dy is to analyze the clinicopathological and
immunohistochemical characteristics of JSGH to explain i
147 Immunohistochemical characterization of infiltrating MCs
148 Immunohistochemical characterization of liver tissue fro
149 ariations, along with histomorphological and
immunohistochemical characterization.
150 e at C-fiber inputs, a view supported by our
immunohistochemical colabeling data.
151 mical analysis of plasma cytokine levels and
immunohistochemical confirmation of microglial activity
152 ned analysis of transcriptomic, protein, and
immunohistochemical data in BALB/c mice showed that estr
153 Here we present morphological and
immunohistochemical data in Neohelice granulata supporti
154 Immunohistochemical data show that a systemically admini
155 Immunohistochemical detection of c-Fos was quantified us
156 alpha-syn expression patterns and levels by
immunohistochemical detection of endogenous alpha-syn in
157 As such, the
immunohistochemical distinction of CTE neuropathology fr
158 tructure and skin dermis of MFS mice through
immunohistochemical evaluation and quantification of ela
159 sies were submitted for histomorphologic and
immunohistochemical evaluation in a blinded fashion as w
160 Immunohistochemical evaluation indicates that pathways a
161 Immunohistochemical evaluation of the spinal lesion at 4
162 ression of HIF1A and VEGFA was determined by
immunohistochemical evaluation of tissue microarrays.
163 ted and processed for histo-morphometric and
immunohistochemical evaluation to determine the extent o
164 othesis that Acomys would have molecular and
immunohistochemical evidence of reduced spinal inflammat
165 The results of this study provide
immunohistochemical evidence that the posterior hyaloid
166 Additionally, an
immunohistochemical examination of E-cadherin, Snail, Sl
167 ected globes underwent histopathological and
immunohistochemical examination.
168 Mycobacterium bovis Detailed postmortem and
immunohistochemical examinations of lesions were perform
169 Immunohistochemical experiments also indicate that IH pe
170 These cancers did not demonstrate any
immunohistochemical features suggestive of Lynch Syndrom
171 itro syncytialization was congruent with the
immunohistochemical findings in preeclamptic placenta as
172 with clinical, radiologic, morphologic, and
immunohistochemical findings is particularly important i
173 Clinical, histopathologic, and
immunohistochemical findings were recorded.
174 Immunohistochemical fluorescent images presented upregul
175 An angiotensin-converting enzyme 2
immunohistochemical H-score was compared across cases.
176 E (polymerase epsilon) cohort, as defined by
immunohistochemical (
IHC) loss of expression of one or m
177 Here, we used
immunohistochemical (
IHC) staining and 7-color multiplex
178 onal information that could be obtained from
immunohistochemical (
IHC) staining.
179 s in the two types of mice was determined by
immunohistochemical-,
immunogold-labeling-, and western
180 ry systems in anuran amphibians, tracing and
immunohistochemical investigations were performed in the
181 FIN-Seq uses
immunohistochemical isolation of nuclei of specific cell
182 signed deep learning model was trained on 45
immunohistochemical Ki67-labelled whole slide images to
183 of S. hispidus using histological sections,
immunohistochemical labeling as well as X-ray microtomog
184 d bone, but the fluorescence of proteins and
immunohistochemical labels was maintained over weeks.
185 Immunohistochemical localization and scoring of K17 immu
186 l lesions stained with hematoxylin-eosin and
immunohistochemical markers (melan-A, microphthalmia-ass
187 Immunohistochemical markers (n = 727 women) and Agilent
188 rafish, we studied circadian distribution of
immunohistochemical markers of the cell division cycle (
189 through the identification of genomic and/or
immunohistochemical markers of tipifarnib sensitivity.
190 Examples include the introduction of novel
immunohistochemical markers that serve as surrogates for
191 led to development of sensitive and specific
immunohistochemical markers, such as STAT6 in solitary f
192 zation and diversity across species, we used
immunohistochemical methods to examine ipRGCs in tree sh
193 four macaque species using histological and
immunohistochemical methods.
194 levance of these experiments is suggested by
immunohistochemical,
microarray, and quantitative RT-PCR
195 No
immunohistochemical or neurobehavioral changes were obse
196 skilled locomotion, electrophysiologic, and
immunohistochemical outcomes were assessed.
197 Clinical, histopathologic, and
immunohistochemical (
p16, SOX10, HMB45, and Ki-67) findi
198 th the exception of PRKAR1A studies, current
immunohistochemical panels cannot reliably distinguish b
199 nocytic intraepithelial lesions, the current
immunohistochemical panels have limited value in distinc
200 Immunohistochemical positivity for p4E-BP1 or insulin-li
201 f these sexually dimorphic CRFR1 cells using
immunohistochemical procedures.
202 more of an organizational mastermind than an
immunohistochemical protocol.
203 To this end, we employed diverse
immunohistochemical protocols to identify key aspects of
204 ected lymph node metastases (LNMs) underwent
immunohistochemical PSMA staining.
205 rrier integrity were assessed by histologic,
immunohistochemical,
quantitative reverse transcription
206 However, PD-L1
immunohistochemical readout is inconsistent with patient
207 A complete histological and
immunohistochemical review of the vascular components wa
208 ions between PET uptake and semiquantitative
immunohistochemical scoring (percentage positive cells x
209 Immunohistochemical screening of 201 patients (2011-2013
210 and 112 various types of ovarian cancers via
immunohistochemical staining and examined LINE-1 promote
211 -PSMA PET/CT findings and PSMA expression in
immunohistochemical staining and generate a cutoff value
212 A wide array of histological and
immunohistochemical staining and mRNA-based gene express
213 Immunohistochemical staining demonstrated that Ebf3 and
214 Immunohistochemical staining demonstrated that tau fragm
215 AiHp found by
immunohistochemical staining especially in corpus biopsi
216 response to photostimulation and verified by
immunohistochemical staining following juxtacellular lab
217 rtrate-resistant acid phosphatase (TRAP) and
immunohistochemical staining for five bone metabolism-re
218 Immunohistochemical staining for infiltrating immune cel
219 In patients with LS with MSI-H/I tumors,
immunohistochemical staining for MMR-D was assessed.
220 Extensive
immunohistochemical staining for myofibroblasts and proc
221 Immunohistochemical staining for PD-L1, PD-L2, CD8, and
222 GPs underwent
immunohistochemical staining for TRPV1.
223 Immunohistochemical staining identified additional benef
224 Specimens were also analyzed by
immunohistochemical staining identifying the laminin (Ln
225 Immunohistochemical staining in an aromatase reporter mo
226 in TILs, defined as greater than 5% positive
immunohistochemical staining in the respective cell popu
227 s with a high SUV in vivo also showed a high
immunohistochemical staining intensity.
228 d hypothalamus using a range of standard and
immunohistochemical staining methods.
229 Immunohistochemical staining of bone marrow biopsies fro
230 These results were confirmed by
immunohistochemical staining of brain tissue sections re
231 Immunohistochemical staining of human cancers for endoge
232 onavirus 2 (SARS-CoV-2) infection by RT-PCR,
immunohistochemical staining of kidney biopsy samples fo
233 Immunohistochemical staining of LS-positive MSI-H/I tumo
234 Immunohistochemical staining of PD-L1 expression in meni
235 Immunohistochemical staining of primary CCPAP tumor spec
236 Immunohistochemical staining of samples obtained from br
237 reatic hormones in plasma, histochemical and
immunohistochemical staining of small intestine, heart,
238 mRNA expression in arterial tissues, robust
immunohistochemical staining of talin 1 was demonstrated
239 In patients,
immunohistochemical staining of tissue microarrays and m
240 s from the TCGA data mining and validated by
immunohistochemical staining on colorectal cancer tissue
241 Immunohistochemical staining on formalin-fixed BCCs from
242 gic pRCC subtype in combination with the MYC
immunohistochemical staining patterns allows a more accu
243 Immunohistochemical staining revealed that cholinergic a
244 Immunohistochemical staining revealed the tumour cells t
245 Immunohistochemical staining showed more ionized calcium
246 Immunohistochemical staining showed that TGLI1, but not
247 Immunohistochemical staining showed that TiO(2) coating
248 Consistent with the mouse model study,
immunohistochemical staining showed that ZO-1 is abundan
249 Immunohistochemical staining was performed for the activ
250 Immunohistochemical staining was used to evaluate protei
251 To confirm the presence of macrophages, CD68
immunohistochemical staining was used.
252 We also used immunoblot analysis,
immunohistochemical staining, and other tools to study u
253 Next, using an Ai9/td reporter and
immunohistochemical staining, annulus fibrosus and nucle
254 Immunohistochemical staining, gene expression profiling,
255 nd analyzed for tumor size and number and by
immunohistochemical staining, immunoblot, and quantitati
256 For
immunohistochemical staining, samples from 26 subjects w
257 Based on
immunohistochemical staining, the tumor xenografts in mi
258 Using
immunohistochemical staining, we demonstrate that TXNDC5
259 yzed by real-time PCR, western blotting, and
immunohistochemical staining.
260 o be up-regulated by quantitative RT-PCR and
immunohistochemical staining.
261 bility to tissue processing for histological/
immunohistochemical staining.
262 vity and efficiency compared to conventional
immunohistochemical staining.
263 rafts were analyzed using flow cytometry and
immunohistochemical staining.
264 Based on
immunohistochemical stainings against synapsin and serot
265 Immunohistochemical stainings for calprotectin in renal
266 Hematoxylin-eosin and
immunohistochemical stainings for tumor-infiltrating lym
267 The addition of melan-A and SOX10
immunohistochemical stains did not downgrade any of the
268 The addition of melan-A and SOX10
immunohistochemical stains resulted in an upgrade of con
269 Employing a range of standard and
immunohistochemical stains we provide a description of t
270 Hematoxylin-eosin and PAX8
immunohistochemical stains were performed on all specime
271 riate cases, bleached preparations and other
immunohistochemical stains, including AE1/AE3 cytokerati
272 hitecture, myeloarchitecture, and a range of
immunohistochemical stains, we describe the systems-leve
273 Here, using a range of architectural and
immunohistochemical stains, we describe the systems-leve
274 Using architectural and
immunohistochemical stains, we observe that the nuclear
275 Using architectural and
immunohistochemical stains, we observe that the organiza
276 cellular occurrence can often be detected by
immunohistochemical stains.
277 Immunohistochemical studies and in vivo two-photon imagi
278 Several
immunohistochemical studies have demonstrated the simila
279 to areas of microvascular proliferation and
immunohistochemical studies localized DCN protein expres
280 Immunohistochemical studies of developing mouse brain fr
281 Immunohistochemical studies previously obtained on the c
282 Immunohistochemical studies revealed that the specific f
283 Immunohistochemical studies showed that tissue damage du
284 Detailed pituitary histological and
immunohistochemical studies were performed at 12 months.
285 Immunohistochemical studies were performed for smooth mu
286 d Ki-67 antibodies were used for comparative
immunohistochemical study.
287 (nodal status, tumour size, tumour grade and
immunohistochemical subtype).
288 of metabolic markers to distinguish various
immunohistochemical subtypes of PAs.
289 categories of molecular information (namely
immunohistochemical subtypes; PAM50 subtypes, which are
290 Breast cancer (BC) comprises four
immunohistochemical surrogate subtypes of which triple-n
291 Immunohistochemical techniques showed that in culture-po
292 Biochemical analyses and
immunohistochemical techniques were used to determine el
293 spheroid culture technologies with advanced
immunohistochemical techniques, this approach will allow
294 Immunohistochemical technology was used to determine the
295 87 cases that underwent additional PCR- and
immunohistochemical testing to define a sensitive ground
296 Sanger sequencing, immunoblotting,
immunohistochemical testing, flow cytometry, and transcr
297 because this requires additional genetic or
immunohistochemical tests.
298 o perform flow cytometric, Western blot, and
immunohistochemical tumor analyses.
299 This detailed histopathologic,
immunohistochemical,
ultrastructural, and molecular card
300 stematic in silico data analysis followed by
immunohistochemical validation identified increased expr